Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
尧唐(上海)生物科技有限公司
{{company.company_channel.channel_name}}
Media Room
Latest
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH
2024-04-02 20:00
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean
2024-03-27 20:00
YolTech Therapeutics to Showcase Breakthroughs in in vivo Gene Editing at TIDES Asia 2024
2024-03-13 20:00
Landmark Clinical Approval for YOLT-201 Obtained by the NMPA
2024-03-04 20:00
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024
2024-01-02 20:30
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
2023-12-17 23:15
1